Invention Grant
- Patent Title: Ophthalmic formulation comprising citicoline carried by liposome for the treatment of glaucoma
-
Application No.: US16342261Application Date: 2017-10-16
-
Publication No.: US10576039B2Publication Date: 2020-03-03
- Inventor: Cristiano Virno , Marco Malizia
- Applicant: Omikron Italia S.r.l.
- Applicant Address: IT Rome
- Assignee: Omikron Italia S.r.l.
- Current Assignee: Omikron Italia S.r.l.
- Current Assignee Address: IT Rome
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: IT102016000103956 20161017
- International Application: PCT/IB2017/056400 WO 20171016
- International Announcement: WO2018/073720 WO 20180426
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K47/18 ; A61K47/36 ; A61P27/06 ; A61K9/00 ; A61K31/7068 ; A61K9/08
Abstract:
The present invention relates to an ophthalmic formulation comprising citicoline and liposomes to be used in treating glaucoma. The inventors have found that the liposomes result to be particularly effective in carrying citicoline in the posterior segment of the eye (vitreous chamber) and in reaching the retina and the optic nerve head.
Public/Granted literature
- US20190321292A1 OPHTHALMIC FORMULATION COMPRISING CITICOLINE CARRIED BY LIPOSOME FOR THE TREATMENT OF GLAUCOMA Public/Granted day:2019-10-24
Information query
